ImmuCell Corporation (ICCC)
| Previous close | 5.04 |
| Open | 5.13 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 5.04 - 5.13 |
| 52-week range | 4.26 - 6.05 |
| Volume | |
| Avg. volume | 7,269 |
| Market cap | 39.142M |
| Beta (5Y monthly) | 0.60 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
ImmuCell Corporation (NASDAQ:ICCC) Q4 2023 Earnings Call Transcript
ImmuCell Corporation (NASDAQ:ICCC) Q4 2023 Earnings Call Transcript February 28, 2024 ImmuCell Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning and welcome to the ImmuCell Corporation reports Fourth Quarter and Year Ended December 31, 2023 Unaudited Financial […]
- Insider Monkey
ImmuCell Corporation (NASDAQ:ICCC) Q3 2023 Earnings Call Transcript
ImmuCell Corporation (NASDAQ:ICCC) Q3 2023 Earnings Call Transcript November 14, 2023 Operator: Good day, everyone, and welcome to the ImmuCell Corporation’s Third Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please note this event is being recorded. And now I would like to turn the conference over to Joe Diaz. Please go ahead. Joe Diaz: […]
- Simply Wall St.
There's No Escaping ImmuCell Corporation's (NASDAQ:ICCC) Muted Revenues
With a price-to-sales (or "P/S") ratio of 2.2x ImmuCell Corporation ( NASDAQ:ICCC ) may be sending very bullish signals...
